[BRIEFING.COM] The stock market closed lower at the index level. The Russell 2000 underperformed, dropping 1.2%, while the S&P 500 (-0.4%), Nasdaq Composite (-0.3%), and Dow Jones Industrial Average (-0.6%). Many names participated in a broad retreat, leading the equal-weighted S&P 500 to decline 0.8%.
NVIDIA (NVDA 130.39, -1.61, -1.2%) underperformed again along with other chipmakers. Broadcom (AVGO 240.23, -9.77, -3.9%) logged a 4% decline and the PHLX Semiconductor Index (SOX) closed 1.6% lower. Gains in Apple (AAPL 253.48, +2.44, +1.0%), Microsoft (MSFT 454.46, +2.87, +0.6%), and Tesla (TSLA 479.86, +16.84, +3.6%), which constitute 16% of the S&P 500, provided some offsetting support to the broader market.
UnitedHealth (UNH 485.52, -12.98, -2.6%) was another influential laggard, along with managed care stocks with pharmacy benefit manager divisions like CVS (CVS 44.04, -2.56, -5.5%). This selling followed comments from President-elect Trump yesterday that he wants to "knock out the drug industry middle man" contributing to higher drug prices.
The 10-yr note yield, which was at 4.44% in front of this morning's data, settled two basis points lower than yesterday at 4.38%. The 2-yr yield, which was at 4.28% before 8:30 ET, settled unchanged from yesterday at 4.24%.
This price action followed the November retail sales report, which showed a soft 0.2% increase in sales, excluding autos. That line item was viewed as a sign of softening in consumer spending activity since the report is not adjusted for price changes, meaning there wasn't any real pickup in volume/demand driving the increase. Also, the $13 billion 20-yr bond reopening was met with relatively weak demand.
Reviewing today's economic data:
Looking ahead, market participants receive the following data tomorrow: